Anticorps Monoclonal anti-Podocalyxin

Podocalyxin Monoclonal Antibody for IHC, IF-P, Indirect ELISA

Hôte / Isotype

Mouse / IgG2a

Réactivité testée

Humain

Applications

IHC, IF-P, Indirect ELISA

Conjugaison

Non conjugué

CloneNo.

4A3C7

N° de cat : 68250-1-PBS

Synonymes

PODXL, 4A3C7, GCTM 2 antigen, GCTM-2 antigen, Gp200



Informations sur le produit

68250-1-PBS cible Podocalyxin dans les applications de IHC, IF-P, Indirect ELISA et montre une réactivité avec des échantillons Humain

Réactivité Humain
Hôte / Isotype Mouse / IgG2a
Clonalité Monoclonal
Type Anticorps
Immunogène Podocalyxin Protéine recombinante Ag12859
Nom complet podocalyxin-like
Masse moléculaire calculée 526 aa, 55 kDa
Poids moléculaire observé60-70 kDa
Numéro d’acquisition GenBankBC093730
Symbole du gène Podocalyxin
Identification du gène (NCBI) 5420
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par protéine A
Tampon de stockage PBS only
Conditions de stockageStore at -80°C. 20ul contiennent 0,1% de BSA.

Informations générales

Podocalyxin, also known as podocalyxin-like protein 1 (PODXL or PCLP1), is a transmembrane glycoprotein belonging to the CD34 family of sialomucins. Podocalyxin was originally identified as the major sialoprotein on podocytes of the kidney glomerulus, but was later found to be expressed on vascular endothelial cells and early hematopoietic progenitors. It Involved in the regulation of both adhesion and cell morphology. In addition, podocalyxin is highly expressed in embryonic stem cells and aberrant expression of podocalyxin has been implicated in a wide range of cancers. Podocalyxin is a protein with a peptide bone of ∼55.5 kDa that undergoes a post‐translational glycosylation, the different molecular mass of podocalyxin indicates the extent and variability of glycosylation patterns (PMID: 17092254).

{{ptg:RelatedPrimaryAntibodies}}